BluePath Capital Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$254K Buy
+1,000
New +$233K 0.14% 119
2024
Q2
Sell
-1,402
Closed -$222K 116
2024
Q1
$222K Sell
1,402
-5,314
-79% -$846K 0.17% 108
2023
Q4
$1.09M Buy
6,716
+1,104
+20% +$169K 0.93% 19
2023
Q3
$874K Buy
+5,612
New +$926K 0.8% 21

Other funds holding JNJ

BluePath Capital Management's JNJ Position: Q2 2026 in Review

BluePath Capital Management opened a new position in Johnson & Johnson (JNJ) in Q2 2026: 1,000 shares worth $254K. The stake represents 0.14% of the portfolio and ranks #119 among its holdings. This is a return to the name: BluePath Capital Management previously reported a position in JNJ as recently as Q1 2024.

BluePath Capital Management first reported a position in JNJ in Q3 2023 and has held it in 4 quarters since. The position peaked at $1.09M in Q4 2023. 1,657 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • BluePath Capital Management held 1,000 shares of Johnson & Johnson worth $254K as of Q2 2026.
  • Johnson & Johnson was a new BluePath Capital Management position in Q2 2026.
  • Johnson & Johnson made up 0.14% of BluePath Capital Management's portfolio in Q2 2026, its #119 holding.
  • BluePath Capital Management first reported a position in Johnson & Johnson in Q3 2023 and has held it in 4 quarters since.
  • BluePath Capital Management's Johnson & Johnson position peaked at $1.09M in Q4 2023.
  • 1,657 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on BluePath Capital Management's 13F filing for Q2 2026, filed 24 Jul 2026.